Know Cancer

or
forgot password
  • cancer clinical trials in oklahoma city, OK

  • hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Neuroblastoma
    Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer, Primary Peritoneal Carcinoma
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Brain Tumor, Central Nervous System Tumor
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Endometrial Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage II Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Cancer Care Associates - Baptist Campus
    Oklahoma City, Oklahoma 73112
    Non-Small Cell Lung Cancer
    Non-small Cell Lung Cancer Study US75 (Z-PACT)
    Cancer Specialists of Oklahoma
    Oklahoma City, Oklahoma 73112
    Non Small Cell Lung Carcinoma
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Endometrial Cancer
    Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Cervical Cancer
    Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Cervical Cancer
    Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
    Gynecologic Oncology and Surgery
    Oklahoma City, Oklahoma 73112
    Ovarian Cancer
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Comprehensive Cancer Center
    Oklahoma City, Oklahoma 73112
    Lung Cancer, Non-small-cell Lung Carcinoma
    Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions
    Oklahoma Medical Research Foundation
    Oklahoma City, Oklahoma 73104
    Melanoma
    Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Gestational Trophoblastic Tumor
    A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Oklahoma Univ. Medical Center
    Oklahoma City, Oklahoma 73104
    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
    Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
    GSK Investigational Site
    Oklahoma City, Oklahoma 73112
    Ovarian Cancer
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Non-small Cell Lung Cancer Registry
    M. Farouk Kanaa, MD, Inc.
    Oklahoma City, Oklahoma 73120
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Brain and Central Nervous System Tumors
    Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Cervical Cancer
    Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia
    Local Institution
    Oklahoma City, Oklahoma
    Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia
    Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Brain and Central Nervous System Tumors
    Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
    The University of Oklahoma
    Oklahoma City, Oklahoma 73104
    Sickle Cell Disease, Iron Overload, Hemolytic Anemia
    Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Sarcoma
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Sarcoma
    Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Cancer Care Associates - Mercy Campus
    Lung Cancer
    Remission and Joint Damage Progression in Early Rheumatoid Arthritis
    Lynn Health Sciences Institute
    Oklahoma City, Oklahoma 73112
    Rheumatoid Arthritis
    Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
    GSK Investigational Site
    Oklahoma City, Oklahoma 73112
    Human Papillomavirus (HPV) Infection, Cervical Neoplasia
    Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects
    Bone and Joint Hospital Research Dept.
    Oklahoma City, Oklahoma 73103
    Arthritis, Rheumatoid, Arthritis, Psoriatic, Ankylosing Spondylitis
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Prostate Cancer, Osteoporosis, Fractures
    Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy
    Oklahoma University Health Sciences Center-Jimmy Everest Center
    Oklahoma City, Oklahoma 73104
    Lymphomas, Tumors
    Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Metastatic Pancreatic Cancer
    Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
    The Lynn Health Science Institute
    Oklahoma City, Oklahoma 73112
    Low Back Pain, Migraine, Diabetic Neuropathies, Osteoarthritis
    A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix
    The University of Oklahoma Health Sciences Center, Center for Research in Women's Health
    Oklahoma City, Oklahoma 73104
    Uterine Cervical Dysplasia
    Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Recurrent Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Squamous Cell, Neoplasms, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Head and Neck Cancer
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
    Boehringer Ingelheim Investigational Site
    Oklahoma City, Oklahoma
    HIV Infections
    Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
    University of Oklahoma Health Sciences Center Dept of OB/GYN
    Oklahoma City, Oklahoma 73104
    Cervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia
    Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate
    Local Institution
    Oklahoma City, Oklahoma
    Leukemia, Myeloid, Chronic, Leukemia, Lymphocytic, Acute, L2
    Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Priapism, Anemia, Sickle Cell
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Brain and Central Nervous System Tumors
    Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Bacterial Infection
    A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Acute Myelogenous Leukemia
    A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Oral Mucositis, Stomatitis
    Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
    University of Oklahoma Health Science Center
    Oklahoma City, Oklahoma 73104
    Malignant Ascites
    S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Head and Neck Cancer
    Cervical Cancer Early Endpoints and Determinants
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Cervical Cancer
    The Second Multicenter Hemophilia Cohort Study
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Liver Decompensation, Hepatocellular Carcinoma, Non-Hodgkin Lymphoma
    Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Prostate Cancer
    Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Infection, Neutropenia, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Head and Neck Cancer, Mucositis, Pain, Radiation Toxicity
    Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Sarcoma
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis
    Site Ref # / Investigator 7709
    Oklahoma City, Oklahoma 73104
    Ulcerative Colitis
    Multi-Center Human Alert Trial to Prevent DVT and PE
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Pulmonary Embolism, Deep Vein Thrombosis, Cancer, Surgery
    Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Bacterial Infections
    Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Cytomegalovirus Infections